Wistar Institute discovers mechanism of action of farnesyltransferase inhibitors Feb. 17, 1999 No Comments
First pivotal trial results reported for marimastat; BB to assess implications for development Feb. 16, 1999 No Comments
Available for licensing from NIH: BOG gene and protein product for Rx, Dx use Feb. 15, 1999 No Comments
Aronex initiates phase I/II trial of Atragen + interferon alfa in renal cell carcinoma Feb. 15, 1999 No Comments